Sponsor or institution
Clinical trials and research at Crossbow Therapeutics, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Crossbow Therapeutics, Inc. that are recruiting, in United States. By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
CBX-663 dose-escalation study in adults with relapsed or refractory myeloid cancers, advanced solid tumors, or glioblastoma
This early-phase trial tests CBX-663 to see if it is safe and tolerable and to get an early sense of activity in adults with relapsed/refractory myeloid cancers, advanced solid tumors, or recurrent glioblastoma.
-
CBX-250 for relapsed or refractory myeloid leukemias.
This will try CBX-250, a new injectable medicine, in people aged 12 and older with relapsed or refractory AML, high-risk MDS, CMML, or CML to see if it can control disease with tolerable side effects.
Quick answers
How many clinical trials run by Crossbow Therapeutics, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.